Recently, a series of EphB4 antibodies has been evaluated for the use of Positron Emission Tomography (PET) in mice xenografted with human HT-29 colon cancer and MDA-MB-231 breast cells, underscoring the value of EphB4 as a target for tumor imaging [23]. This evidence concerns the gene EPHB4 and malignant colon neoplasm.